A carregar...
Bevacizumab combined with chemotherapy for glioblastoma: a meta-analysis of randomized controlled trials
Bevacizumab, as antibodies, were applied to inhibit tumor angiogenesis by preventing activation of vascular endothelial growth factor receptor. We analyzed four clinical trials, including 607 patients, to investigate the efficacy and safety of bevacizumab when combined with chemotherapy for the trea...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5593645/ https://ncbi.nlm.nih.gov/pubmed/28915674 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16924 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|